UK Equities

Why UK equities?

With thousands of businesses from 60 countries around the world listed in the UK, its stock market remains one of the most exciting choices for investors today.

Deep, liquid markets and world-leading regulation, corporate governance and legal and professional services support make UK equities a must-have for any global equity portfolio.

Home advantage for UK investors

During the latest quarterly webinar hosted by Square Mile’s Richard Romer-Lee, Portfolio Managers: Chris St John (UK Mid Cap), Simon Young (UK Equity Income) and Dan Harlow (UK Small Cap), covered a quick review of 2020, reasons for optimism in the year ahead, the UK’s lack of technology exposure and whether this will hold back the market, upcoming IPOs in 2021, the outlook for dividends and ESG investing.

Our expertise

Our UK equity team’s expertise spans the entire market cap spectrum.

Whether you’re aiming to capture growth from the dynamic small cap sector, benefit from exciting opportunities offered by innovative mid-cap companies, or gain exposure to internationally-focused, mega-cap stocks in the FTSE 100 Index, we have a range of funds to cover your needs.

UK equities in focus

  • 7

    dedicated UK equities managers

  • 20

    years of experience*

  • £5.6bn

    UK assets under management

Source: AXA IM as 31/08/2019
*Average years of experience of a Portfolio Manager

42 insights found

UK Equities
5 minute read

UK Multi-Cap strategy: The UK and European Union have finalised a trade agreement

Equity markets, particularly in the UK, rose strongly in December, buoyed both by optimism related to the imminent rollout of the Pfizer and Astrazeneca Covid vaccine and news that the UK and Europea ...

UK Equities

Home advantage for UK investors

UK Equities Webinar with Chris St John, Dan Harlow & Simon Young

UK Equities
5 minute read

UK companies: why now?

In this piece, we aim to set out some of the core arguments for investing in the UK today, and why UK-based investors in particular should be considering their home market.

UK Equities
5 minute read

UK Mid Cap strategy: Mergers and acquisitions remains a feature of the UK market

Equity markets, particularly in the UK, rose strongly in December, buoyed both by optimism related to the imminent rollout of the Pfizer and Astrazeneca Covid vaccine and news that the UK and Europea ...

UK Equities
5 minute read

UK Multi-Cap strategy: We continue to focus on companies where balance sheet strength is supportive of that growth

The initial announcement, from Pfizer, catalysed a dramatic ‘style rotation’ as investors became immediately more optimistic about a global economic recovery.

UK Equities
5 minute read

UK Mid Cap strategy: Equity markets rose strongly in November

Equity markets rose strongly in November following the release of positive late stage trial data from three Coronavirus vaccine candidates.